Novistra Capital
transaction-bg-2560x945

November 2019

India

Novistra Capital advised ACN Healthcare on its merger with Rapid Care’s RCM business

Client

ACN Healthcare

Deal Type

Buy-Side M&A

Deal Team

Ripun-1-120x120

Ripun Jai Mehta

Managing Partner

Pankaj-1-120x120

Pankaj Arora

Managing Director

Client Description

ACN Healthcare is an end-to-end revenue cycle management (RCM) company providing medical billing, coding, and back-office services to physician practices, hospitals, and medical billing companies across the United States. With three delivery centers in Bangalore, Hyderabad, and Visakhapatnam, and a U.S. sales office in Orlando, ACN combines global delivery with local client engagement.

Rapid Care Group is a Chennai-based healthcare support services provider with a focus on medical billing, coding, transcription, and medical document review. The company serves U.S.-based physician groups and maintains three sales offices in the U.S. alongside its India-based delivery operations.

Approach

ACN Healthcare engaged Novistra Capital to advise on a strategic combination with a complementary player to enhance scale, service breadth, and market access. Novistra identified Rapid Care’s RCM division as a strong operational and cultural fit, and structured a transaction that would consolidate delivery capabilities while creating a more comprehensive offering for U.S. healthcare providers.

With deep experience in healthcare outsourcing and RCM services, Novistra led the deal from diligence through to execution, aligning shareholder priorities and creating a platform for post-merger integration.

Outcome

ACN Healthcare merged with Rapid Care’s revenue cycle management business, creating a combined platform with enhanced delivery capabilities, multi-city infrastructure, and expanded client reach in both the U.S. and India. The transaction strengthens the group’s competitive position in a rapidly consolidating healthcare BPO sector.

This deal reflects Novistra’s long-standing focus on healthcare services, BPO, and cross-border platform integration across the U.S.–India corridor.

Press Releases

healthcare-2560x390

November, 2019

Novistra Capital advises ACN Healthcare on its merger with Rapid Care’s RCM business

Read more

Related Transactions

Acquired

Buy-side advisor to CX1 Capital

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Outcome: Exclusive buy-side advisor to CX1 Capital, a tech-driven investment firm that focuses on lower middle market buy & build strategies using AI.

Acquired by

A portfolio company of

Sell-side advisor to CTI Data

Novistra Capital advises CTI Data on its sale to OneSix

Exclusive sell-side advisor to CTI Data, a leading data consultancy, on its sale to OneSix,...

Outcome: Acquisition creates a differentiated Snowflake data and scaled AI platform.

Acquired by

A portfolio company of

Sell-side advisor to Yexle

Novistra Capital advises Yexle on its sale to IGT Solutions, an EQT portfolio company

Exclusive sell-side advisor to Yexle, a leading Appian solutions and services partner.

Outcome: Added cutting-edge Appian delivery capabilities to IGT’s digital transformation practice.

Acquired by

A portfolio company of

Sell-side advisor to NetServ

Novistra Capital advised NetServ on its acquisition by Accion Labs, a portfolio company of TA Associates

Served as exclusive sell-side advisor to NetServ on its acquisition by Accion Labs, a global...

Outcome: Strengthened engineering capabilities and delivery presence across key markets

Acquired by

A portfolio company of

Sell-side advisor to SG Analytics

Novistra Capital advised SG Analytics on its acquisition by Straive, a portfolio company of EQT

SG Analytics engaged Novistra Capital as its exclusive sell-side advisor on its acquisition by Straive,...

Outcome: Created one of the leading integrated data and analytics platforms

Acquired by

A portfolio company of

Sell-side advisor to Cloud Development Resources

Novistra Capital advised Cloud Development Resources on its majority sale to emids

CDR engaged Novistra Capital to lead a targeted process culminating in its sale to emids,...

Outcome: Established the healthcare industry’s first dedicated low-code practice

Majority investment in

Buy-side advisor to Excelra

Novistra Capital advised Excelra on its majority investment in Anilitiks

Served as exclusive buy-side advisor to Excelra on its acquisition of Anilitiks, strengthening Excelra’s HEOR...

Outcome: Expanded Excelra’s data-driven Life Sciences solutions portfolio

License agreement with

Financial advisor to IDD Bio Tech

Novistra Capital advised IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs

IDD Biotech appointed Novistra Capital to structure and negotiate a licensing deal for its CD19...

Outcome: Exclusive licensing agreement with Enzene Biosciences completed

Acquired by

Sell-side advisor to Pacific BPO

Novistra Capital advised Pacific BPO on its sale to Access Healthcare

Exclusive advisor to Pacific BPO on its sale to Access Healthcare, creating one of the...

Outcome: Completed sale of Pacific BPO to Access Healthcare

Acquired by

Sell-side advisor to Global Revenue Cycle Partners

Novistra Capital advises Global Revenue Cycle Partners on its majority exit to ACN Technologies

Advised Global Revenue Cycle Partners on its majority sale to ACN Technologies, creating an integrated...

Outcome: Leveraged ACN’s US and European presence to expand offerings

Rectangle-426-1-scaled-2560x718

Clarity starts with
a conversation